Phase II study and biomarker analysis of cetuximab combined with modified FOLFOX6 in advanced gastric cancer

This prospective study was conducted with the Korean Cancer Study Group to evaluate the efficacy and safety of cetuximab combined with modified FOLFOX6 (mFOLFOX6) as first-line treatment in recurrent or metastatic gastric cancer and to identify potential predictive biomarkers. Patients received cetu...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Main Authors: Han, S-W, Oh, D-Y, Im, S-A, Park, S R, Lee, K-W, Song, H S, Lee, N-S, Lee, K H, Choi, I S, Lee, M H, Kim, M A, Kim, W H, Bang, Y-J, Kim, T-Y
Formato: Artigo
Idioma:Inglês
Publicado em: Nature Publishing Group 2009
Assuntos:
Clinical Study
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC2634707/
https://ncbi.nlm.nih.gov/pubmed/19127259
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1038/sj.bjc.6604861
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados